Precision medicine approach to discover the effective therapy for Hydroxychloroquine No respondents in COVID-19
Author(s):
Keerthi G S Nair, Anuraj J, Athira S, P Manoj Kumar
Keywords:
Abstract
The world is gearing up to battle against the Coronavirus disease 19 (COVID-19) outbreak which has already led to more than 323,256 deaths and 4,893,186 confirmed cases globally as on May 22, 2020 [1]. There are currently no drugs licensed for the treatment or prevention of COVID-19. While several drug trials are ongoing, advisories were published on the use of hydroxychloroquine as prophylaxis for SARS-CoV-2 infection [2-4]. The existence of hydroxychloroquine failure was even recorded in many cases [5] and that is to be suggested for the resistance developed.
Article Details
Unique Paper ID: 155020

Publication Volume & Issue: Volume 8, Issue 12

Page(s): 1228 - 1229
Article Preview & Download


Share This Article

Conference Alert

NCSST-2021

AICTE Sponsored National Conference on Smart Systems and Technologies

Last Date: 25th November 2021

SWEC- Management

LATEST INNOVATION’S AND FUTURE TRENDS IN MANAGEMENT

Last Date: 7th November 2021

Go To Issue



Call For Paper

Volume 10 Issue 1

Last Date for paper submitting for March Issue is 25 June 2023

About Us

IJIRT.org enables door in research by providing high quality research articles in open access market.

Send us any query related to your research on editor@ijirt.org

Social Media

Google Verified Reviews

Contact Details

Telephone:6351679790
Email: editor@ijirt.org
Website: ijirt.org

Policies